Clinical Trial Update: A Study to Test Inavolisib Treatment in Participants With Metastatic Castration-Resistant Prostate Cancer [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial to test Inavolisib for metastatic castration-resistant prostate cancer is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Castration-resistant Prostate Cancer

Drugs mentioned

• Inavolisib (Inavolisib)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Metastatic Castration-Resistant Prostate Cancer | Phase 2 | Status: RECRUITING